Lisuride

DRUG2 trials

Sponsors

National Institute on Drug Abuse (NIDA), Axxonis Pharma AG

Conditions

Cocaine-Related DisordersRestless Legs Syndrome

Phase 1

Infusion Laboratory: Protocol 2 (Lisuride) - 3

National Institute on Drug Abuse (NIDA)Cocaine-Related Disorders

Start: 1996-03-31Target: 2Updated: 2017-01-11

Phase 3

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

CompletedNCT00367822

Axxonis Pharma AGRestless Legs Syndrome

Target: 300Updated: 2012-03-07